Shifting care for patients with chronic obstructive pulmonary disease (COPD) from the hospital to the home reduced hospital readmissions by 64% and emergency department visits by 52%, a Canadian program found.
Patients with chronic obstructive pulmonary disease (COPD) who received care in their homes had an improved quality of life, according to the results of a Canadian program.
The INSPIRED program shifted chronic care for COPD from the hospital to the home, which reduced hospital readmissions by 64% and emergency department (ED) visits by 52%. The program was first implemented 2014-2015 and there are now results for more than 2000 patients with COPD who have participated in the program.
Through INSPIRED, healthcare teams identify patients who visit the ED or are hospitalized with advanced COPD and provide them with written action plans for managing their disease, follow-up calls after hospital discharge, and at-home self-management education and psychosocial support.
“Too often, people with chronic diseases like COPD end up in hospital because the care they need is not available in the community,” Maureen O’Neil, president of the Canadian Foundation for Healthcare Improvement (CFHI), said in a statement. “INSPIRED provides the services patients and their families tell us they need to manage their disease outside of hospital and now we are expanding this innovative collaboration to benefit more patients.”
The CFHI is providing 1.4 million Canadian dollars (approximately 1.1 million US dollars) in funding to scale up the INSPIRED programs to additional providers, sites, and patients. For the next phase of the program, collaborative teams will reach an additional 2300 people living with advanced COPD by March 2019.
According to CFHI, a third-party analysis found that nearly 70,000 ED visits and 400,000 hospital bed days could be prevented if the program reached 5800 patients annually by 2021. The expansion of the program would result in avoiding 688 million Canadian dollars (more than 557 million US dollars) in acute care costs. Every 1 Canadian dollar invested in INSPIRED could prevent 21 Canadian dollars in hospital-based costs.
“These results are important because they show we can keep people with chronic disease out of the hospital by partnering with them to reinvent the way we deliver care, so it meets their needs,” said Maria Judd, vice president of programs at CFHI.
Sequencing CAR T and Bispecifics for Multiple Myeloma: Tyler Sandahl, PharmD
July 8th 2025Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, explains that sequencing novel multiple myeloma therapies with CAR T-cell therapy is generally prioritized first for eligible patients, while bispecific antibodies are reserved for later lines or for patients unable to tolerate CAR T.
Read More
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen
Driving Value via Outcomes-Based Pricing and EHR Interoperability: Tyler Sandahl, PharmD
July 7th 2025Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, discussed the complexities of alternative payment models for chimeric antigen receptor T-cell and bispecific therapies and the need for improved data sharing in cancer care.
Read More
Moving Evidence From Research to Practice: Q&A With Ken Cohen, MD
June 23rd 2025In 2025, each issue of Population Health, Equity & Outcomes will feature a profile of a health system leader transforming care in their area of expertise. This issue spotlights a conversation with Ken Cohen, MD, executive director of translational research at Optum Health.
Read More
Many Patients Stop GLP-1s Before Reaching Target Dose: Hamlet Gasoyan, PhD
June 19th 2025Discontinuing the weight loss treatment before hitting the recommended maintenance dose contributes to low-value care despite provider follow-up and efforts to manage side effects, says Hamlet Gasoyan, PhD, Cleveland Clinic.
Read More